Vericel VCEL 深 滬
等待開盤 10-03 09:30:00 美东时间
31.52
+0.610
+1.97%
華盛通- 最 高31.575
- 今 開31.02
- 成交量 46.33万股
- 最 低 30.50
- 昨 收 30.91
- 總市值 15.91亿
- 52周最高 63.00
- 市盈率 靜 157.21
- 換手率 0.00%
- 52周最低 29.24
- 委 比 66.12%
- 總股本 5046.02万
- 歷史最高 68.94
- 量 比 0.60
- 振 幅 3.48%
- 歷史最低 1.11
- 每 手 1
- 風險率 8.61%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BTIG Downgrades Vericel to Neutral
BTIG analyst Ryan Zimmerman downgrades Vericel (NASDAQ:VCEL) from Buy to Neutral.
09-17 18:07
美股大行评级 | 花旗、小摩分别上调苹果目标价；瑞穗上调Robinhood目标价从99美元升至120美元
今日重点评级关注：花旗：维持Apellis Pharmaceuticals"买入"评级，目标价从46美元升至52美元；BTIG：维持Strategy"买入"评级，目标价从620美元升至700美元
08-04 09:30
Canaccord Genuity Maintains Buy on Vericel, Lowers Price Target to $58
Canaccord Genuity analyst Caitlin Cronin maintains Vericel (NASDAQ:VCEL) with a Buy and lowers the price target from $61 to $58.
08-02 04:58
Vericel shares are trading lower after the company reported a Q2 revenue miss.
Vericel shares are trading lower after the company reported a Q2 revenue miss.
07-31 20:45
Vericel Reaffirms Full-year 2025 Profitability Guidance Of Gross Margin Of 74% And Adjusted EBITDA Margin Of 26%
2025 Financial GuidanceReaffirmed MACI full-year revenue growth in the low 20% rangeUpdated Burn Care revenue guidance for the second half of 2025 to be in line with recent run rate of approximately $10 million per
07-31 20:11
Earnings Scheduled For July 31, 2025
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (...
07-31 16:32
Here are the major earnings before the open Thursday
Major earnings expected before the bell on Thursday include: AbbVie (OTC:ABBY) Bristol-Myers Squibb Company (BMY) Mastercard Incorporated (MA) CVS Health Corporation (CVS) Shell plc (SHEL) Other earni...
07-31 06:00
Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025
<p>Vericel Corporation, a leader in advanced therapies for sports medicine and severe burn care, announced it will report its second-quarter 2025 financial results on July 31, 2025. Management will host a conference call and webcast at 8:30 a.m. ET to discuss financial results and business highlights. The live webcast can be accessed on Vericel's Investor Relations website, with presentation slides and a replay available. Investors can join by ph...
07-17 12:30
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025
Vericel Corporation will participate in a fireside chat at the Truist Securities MedTech Conference on June 17, 2025. A webcast will be available on its Investor Relations website. The company specializes in advanced therapies for sports medicine and severe burn care, with products including MACI for knee cartilage repair, Epicel for burn treatment, and NexoBrid for eschar removal. More information is available at www.vcel.com.
06-10 12:30
美股大行评级 | 高盛上调微软目标价从480美元至550美元，Snowflake获多家机构上调目标价！
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1132593314765758464.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持IDEAYA Biosciences(IDYA)"超配"评级，目标价从63美元升至66美元</p> <p>• Needham：上调Inogen(INGN)评级至"买入"，目标价12美元</p> <p>• E
05-23 11:19
